[PDF][PDF] 2022 年免疫学研究热点回眸

黄波 - 科技导报, 2023 - kjdb.org
摘要全球科学家在新冠病毒疫情的巨大挑战中从未停止免疫学研究的步伐, 2022
年免疫学仍然取得了长足进展. 概述了2022 年免疫学研究的热点及进展, 包括T 细胞记忆 …

Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment

PP Banerjee, S Srivastava - Handbook of Oncobiology: From Basic to …, 2023 - Springer
The biological function of the male hormones (androgens) is orchestrated through the
activation of the androgen receptor-mediated signaling events that are central to the …

Androgen blockade primes NLRP3 in macrophages to induce tumor phagocytosis

K Chaudagar, S Rameshbabu, S Mei, T Hirz, YM Hu… - bioRxiv, 2023 - biorxiv.org
Immune-based therapies induce durable remissions in subsets of patients across multiple
malignancies. However, there is limited efficacy of immunotherapy in metastatic castrate …

Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors

M Mengoni, AD Braun, MS Hinnerichs… - JDDG: Journal der …, 2024 - Wiley Online Library
Background The introduction of tyrosine kinase inhibitors (TKI) has greatly improved the
management of metastatic melanoma. Recent studies have uncovered a relationship …

ERBB4 Drives the Proliferation of BRAF-WT Melanoma Cell Lines

LM Lucas, RL Cullum, JN Woggerman, V Dwivedi… - medRxiv, 2022 - medrxiv.org
Metastatic skin cutaneous melanomas remain a significant clinical problem. In particular,
those melanomas that do not contain a gain-of-function BRAF allele remain challenging to …

Off-targets of BRAF inhibitors disrupt endothelial signaling and differentially affect vascular barrier function

S Bromberger, Y Zadorozhna, JM Ressler, S Holzner… - bioRxiv, 2023 - biorxiv.org
Targeted therapies against mutant BRAF are effectively used in combination with MEK
inhibitors (MEKi) to treat advanced melanoma. However, treatment success is affected by …

[HTML][HTML] Молекулярные механизмы полового диморфизма в канцерогенезе

ГА Белицкий, КИ Кирсанов, ЕА Лесовая… - Успехи …, 2023 - cyberleninka.ru
Заболеваемость злокачественными новообразованиями нерепродуктивных органов,
как карциномами, так и саркомами, и смертность от них у мужчин в 1, 5 раза выше, чем …

Umfassende Analyse des Einflusses der Body Composition auf die Wirksamkeit und das Nebenwirkungsprofil einer Systemtherapie mit Tyrosinkinaseinhibitoren bei …

M Mengoni, AD Braun, MS Hinnerichs… - JDDG: Journal der …, 2024 - Wiley Online Library
Zusammenfassung Hintergrund Die Einführung von Tyrosinkinaseinhibitoren (TKI) hat die
Behandlung von Patienten mit metastasiertem Melanom erheblich verbessert. Aktuelle …

Breast cancer progression and metastasis to lymph nodes reveals cancer cell plasticity and MHC class II-mediated immune regulation

PJ Lei, ER Pereira, P Andersson, Z Amoozgar… - bioRxiv, 2022 - biorxiv.org
Tumor-draining lymph nodes are critical sites for generating tumor antigen-specific T cells
and are associated with durable immune responses. However, lymph nodes are often the …

The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma

JH Raymond, M Pouteaux, V Petit, Z Aktary, F Luciani… - bioRxiv, 2022 - biorxiv.org
Although tremendous progress has been made in understanding the mechanisms leading to
cancer, those governing metastases are still poorly understood. E-cadherin (Ecad) is a cell …